Literature DB >> 24491582

Delayed malignant transformation of petroclival meningioma to chondrosarcoma after stereotactic radiosurgery.

Rohan R Lall1, Rishi R Lall1, Timothy R Smith1, Kyung-Hwa Lee2, Qinwen Mao2, John A Kalapurakal3, Maryanne H Marymont3, James P Chandler4.   

Abstract

Stereotactic radiosurgery (SRS) is often used as adjuvant treatment for residual or recurrent tumor following microsurgical resection of posterior fossa meningiomas. SRS is associated with excellent rates of local control, however long-term complications remain unclear. Secondary malignancy is an often discussed but rarely described complication of SRS. We present a 56-year-old woman who underwent near total resection of a petroclival meningioma, followed by two episodes of SRS over the ensuing 8 years for local recurrence. She returned 14 years after initial diagnosis with neurologic deterioration and was found to have massive recurrence. Pathology was consistent with high-grade chondrosarcoma. The tumor continued to progress despite debulking and proton-beam therapy and the patient died of medical complications. To our knowledge this is the first report of malignant transformation of a meningioma to high-grade chondrosarcoma, further notable due to the remarkable clinical course and delayed presentation after initial surgery and radiosurgery. Though this may have been a de novo tumor, it is also possible that this represents a case of radiation-induced neoplasm. Although SRS continues to gain favor as a treatment modality, delayed malignant degeneration is a potential complication and physicians should counsel patients of this risk.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chondrosarcoma; Malignant degeneration; Meningioma; Neuropathology; Radiosurgery; SRS; Stereotactic radiosurgery

Mesh:

Year:  2013        PMID: 24491582     DOI: 10.1016/j.jocn.2013.11.015

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

Review 1.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

Review 2.  Petroclival meningiomas: update of current treatment and consensus by the EANS skull base section.

Authors:  Lorenzo Giammattei; P di Russo; D Starnoni; T Passeri; M Bruneau; T R Meling; M Berhouma; G Cossu; J F Cornelius; D Paraskevopoulos; I Zazpe; E Jouanneau; L M Cavallo; V Benes; V Seifert; M Tatagiba; H W S Schroeder; T Goto; K Ohata; O Al-Mefty; T Fukushima; M Messerer; R T Daniel; S Froelich
Journal:  Acta Neurochir (Wien)       Date:  2021-03-19       Impact factor: 2.216

3.  Expression of decitabine-targeted oncogenes in meningiomas in vivo.

Authors:  Volker Senner; Benjamin Brokinkel; Julian Canisius; Andrea Wagner; Eva Christina Bunk; Dorothee Cäcilia Spille; Louise Stögbauer; Oliver Grauer; Katharina Hess; Christian Thomas; Werner Paulus; Walter Stummer
Journal:  Neurosurg Rev       Date:  2022-04-21       Impact factor: 2.800

4.  Recurrent intraventricular meningioma with malignant transformation.

Authors:  Jasmit Singh; Hrushikesh Kharosekar; Vernon Velho
Journal:  Asian J Neurosurg       Date:  2017 Jul-Sep

5.  Predictors of early progression of surgically treated atypical meningiomas.

Authors:  Karol P Budohoski; James Clerkin; Christopher P Millward; Philip J O'Halloran; Mueez Waqar; Seamus Looby; Adam M H Young; Mathew R Guilfoyle; Diana Fitzroll; Abel Devadass; Kieren Allinson; Michael Farrell; Mohsen Javadpour; Michael D Jenkinson; Thomas Santarius; Ramez W Kirollos
Journal:  Acta Neurochir (Wien)       Date:  2018-06-30       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.